Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gillies

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Ophthalmology|January 15, 2020
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, et al.
Acta Ophthalmologica|November 16, 2020
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, et al.
American Journal of Ophthalmology|May 31, 2021
Outer Retinal Layer Thickening Predicts the Onset of Exudative Neovascular Age-Related Macular DegenerationAlessandro Invernizzi, Salvatore Parrulli, Davide Monteduro, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2025
[Bevacizumab in age-related macular degeneration: more injections, better vision, at lower costs]Haras Mhmud, Odette A M Tigchelaar-Besling, Jeroen P Vermeulen, et al.
British Journal of Pharmacology|March 3, 2019
Simvastatin protects photoreceptors from oxidative stress induced by all-trans-retinal, through the up-regulation of interphotoreceptor retinoid binding proteinTing Zhang, Mark Gillies, Ying Wang, et al.
Journal of Epidemiology and Community Health|May 16, 2024
Sex differences in risk of incident microvascular and macrovascular complications: a population-based data-linkage study among 25 713 people with diabetesAlice A Gibson, Emma Cox, Francisco J Schneuer, et al.
Diabetologia|November 17, 2018
Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse modelsKa Ka Ting, Yang Zhao, Weiyong Shen, et al.
Ophthalmology and Therapy|July 8, 2024
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical PracticeEloi Debourdeau, Helene Beylerian, Vuong Nguyen, et al.
Eye (London, England)|May 4, 2022
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 12, 2026
RWC Update: Gene Therapy in Common Retinal Disorders: Hope, Hype, or Near-term Reality?; 1.4-mm Trophy; Persistent Fetal Vasculature with Tractional Retinal DetachmentAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Ophthalmology|January 15, 2020
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, et al.
Acta Ophthalmologica|November 16, 2020
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, et al.
American Journal of Ophthalmology|May 31, 2021
Outer Retinal Layer Thickening Predicts the Onset of Exudative Neovascular Age-Related Macular DegenerationAlessandro Invernizzi, Salvatore Parrulli, Davide Monteduro, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2025
[Bevacizumab in age-related macular degeneration: more injections, better vision, at lower costs]Haras Mhmud, Odette A M Tigchelaar-Besling, Jeroen P Vermeulen, et al.
British Journal of Pharmacology|March 3, 2019
Simvastatin protects photoreceptors from oxidative stress induced by all-trans-retinal, through the up-regulation of interphotoreceptor retinoid binding proteinTing Zhang, Mark Gillies, Ying Wang, et al.
Journal of Epidemiology and Community Health|May 16, 2024
Sex differences in risk of incident microvascular and macrovascular complications: a population-based data-linkage study among 25 713 people with diabetesAlice A Gibson, Emma Cox, Francisco J Schneuer, et al.
Diabetologia|November 17, 2018
Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse modelsKa Ka Ting, Yang Zhao, Weiyong Shen, et al.
Ophthalmology and Therapy|July 8, 2024
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical PracticeEloi Debourdeau, Helene Beylerian, Vuong Nguyen, et al.
Eye (London, England)|May 4, 2022
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 12, 2026
RWC Update: Gene Therapy in Common Retinal Disorders: Hope, Hype, or Near-term Reality?; 1.4-mm Trophy; Persistent Fetal Vasculature with Tractional Retinal DetachmentAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Pageof 12